Beneficial Effects of Hypercapnic Acidosis on the Inhibition of Transforming Growth Factor β-1-induced Corneal Fibrosis in Vitro

References

• Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17–45.
   PubMed Web of Science ®Google Scholar
• Karamichos D, Guo XQ, Hutcheon AE, Zieske JD. Human corneal fibrosis: an in vitro model. Invest Ophthalmol Vis Sci. 2010;51:1382–88.
   PubMed Web of Science ®Google Scholar
• Das AV, Basu S. Indications and prognosis for keratoplasty in eyes with severe visual impairment and blindness due to corneal disease in India. Br J Ophthalmol. 2020. doi:10.1136/bjophthalmol-2019-315361.
   Web of Science ®Google Scholar
• Tandon A, Tovey JC, Sharma A, Gupta R, Mohan RR. Role of transforming growth factor beta in corneal function, biology and pathology. Curr Mol Med. 2010;10:565–78.
   PubMed Web of Science ®Google Scholar
• Ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci. 2004;29:265–73.
   PubMed Web of Science ®Google Scholar
• Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea. 2004;23:S25–S30.
   PubMedGoogle Scholar
• Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113–29.
   PubMed Web of Science ®Google Scholar
• Feng XH, Derynck R. Specificity and versatility in TGF-Beta signaling through Smads. Annu Rev Cell Dev Biol. 2005;21:659–93.
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001;12:27–36.
   PubMed Web of Science ®Google Scholar
• Shibata K, Cregg N, Engelberts D, Takeuchi A, Fedorko L, Kavanagh BP. Hypercapnic acidosis may attenuate acute lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med. 1998;158:1578–84.
   PubMed Web of Science ®Google Scholar
• Ladilov Y. Preconditioning with hypercapnic acidosis: hope for the ischemic brain. Neurosci Lett. 2012;523:1–2.
   PubMed Web of Science ®Google Scholar
• Takeshita K, Suzuki Y, Nishio K, Takeuchi O, Toda K, Kudo H, Miyao N, Ishii M, Sato N, Naoki K, et al. Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-[kappa]B activation. Am J Respir Cell Mol Biol. 2003;29(1):124–32.
   PubMed Web of Science ®Google Scholar
• O’Toole D, Hassett P, Contreras M, Higgins BD, McKeown ST, McAuley DF, O’Brien T, Laffey JG. Hypercapnic acidosis attenuates pulmonary epithelial wound repair by an NF-kappaB dependent mechanism. Thorax. 2009;64:976–82.
   PubMed Web of Science ®Google Scholar
• Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013;32:1549–59.
   PubMed Web of Science ®Google Scholar
• Luo K. Signaling cross talk between TGF-β/Smad and other signaling pathways. Cold Spring Harb Perspect Biol. 2017;9:1. doi:10.1101/cshperspect.a022137.
   Web of Science ®Google Scholar
• Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, et al. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene. 2003;22(3):412–25.
   PubMed Web of Science ®Google Scholar
• Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res. 2008;314:2725–38.
   PubMed Web of Science ®Google Scholar
• Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R, Ventura F. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J Biol Chem. 2000;275:28937–46.
   PubMed Web of Science ®Google Scholar
• Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Bottinger EP. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 2000;14:187–97.
   PubMed Web of Science ®Google Scholar
• Liang CM, Tai MC, Chang YH, Chen YH, Chen CL, Lu DW, Chen JT. Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy. Acta Ophthalmol. 2011;89:e505–e514.
   PubMed Web of Science ®Google Scholar
• Liang CC, Park AY, Guan JL. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–33.
   PubMed Web of Science ®Google Scholar
• He PM, He S, Garner JA, Ryan SJ, Hinton DR. Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. Biochem Biophys Res Commun. 1998;249:253–57.
   PubMed Web of Science ®Google Scholar
• Mazure A, Grierson I. In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1992;33:3407–16.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Aoshiba K, Itoh M, Nakamura H, Yamaguchi K. Hypercapnia accelerates wound healing in endothelial cell monolayers exposed to hypoxia. Open Respir Med J. 2013;7:6–12.
   PubMedGoogle Scholar
• Wilson SE. Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency. Exp Eye Res. 2012;99:78–88.
   PubMed Web of Science ®Google Scholar
• Santhiago MR, Singh V, Barbosa FL, Agrawal V, Wilson SE. Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits. Exp Eye Res. 2011;93:786–89.
   PubMed Web of Science ®Google Scholar
• Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res. 2010;91:238–45.
   PubMed Web of Science ®Google Scholar
• Chandler HL, Tan T, Yang C, Gemensky-Metzler AJ, Wehrman RF, Jiang Q, Peterson CMW, Geng B, Zhou X, Wang Q, et al. MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents. Commun Biol. 2019;2:71.
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Ramana KV. Focus on molecules: nuclear factor-kappaB. Exp Eye Res. 2009;88:2–3.
   PubMed Web of Science ®Google Scholar
• Lan W, Petznick A, Heryati S, Rifada M, Nuclear Factor-κB: TL. central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012;10:137–48.
   PubMed Web of Science ®Google Scholar
• Kimura K, Orita T, Kondo Y, Zhou H, Nishida T. Upregulation of matrix metalloproteinase expression by poly(I:C) in corneal fibroblasts: role of NF-κB and interleukin-1ß. Invest Ophthalmol Vis Sci. 2010;51:5012–18.
   PubMed Web of Science ®Google Scholar
• Bukowiecki A, Hos D, Cursiefen C, Eming SA. Wound-Healing Studies in Cornea and Skin: parallels, Differences and Opportunities. Int J Mol Sci. 2017;18:1257.
   PubMed Web of Science ®Google Scholar
• Masterson C, O’Toole D, Leo A, McHale P, Horie S, Devaney J, Laffey JG. Effects and Mechanisms by Which Hypercapnic Acidosis Inhibits Sepsis-Induced Canonical Nuclear Factor-κB Signaling in the Lung. Crit Care Med. 2016;44:e207–e217.
   PubMed Web of Science ®Google Scholar
• Lin LT, Chen JT, Tai MC, Chen YH, Chen CL, Pao SI, Hsu CR, Liang CM. Protective effects of hypercapnic acidosis on ischemia-reperfusion-induced retinal injury. PLoS One. 2019;14:e0211185.
   PubMed Web of Science ®Google Scholar